Quantitative clotting assay for activated factor vii

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/56 (2006.01) G01N 33/68 (2006.01) G01N 33/86 (2006.01) G01N 33/96 (2006.01)

Patent

CA 2108282

An assay for activated factor VII (factor VIIa) has been developed using truncated tissue factor (TF), a soluble mutant form of TF that retains the cofactor function of TF toward factor VIIa Unlike full-length TF, however, tTF appears not to sup- port the conversion of factor VII to VIIa. As a result, the tTF assay for factor VIIa is free from interference from factor VII in the plasma and is therefore specific for factor VIIa. The assay is much simpler than existing assays, because it is a single-stage clot. ting assay performed almost identically to a PT assay. It is also considerably more sensitive than current assays for factor VIIa in plasma. Since he tTF assay is calibrated against a factor VIIa standard, it yields an absolute concentration of factor VIIa in ng/ ml.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Quantitative clotting assay for activated factor vii does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quantitative clotting assay for activated factor vii, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quantitative clotting assay for activated factor vii will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1631232

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.